Bernard Vandercam
Impact in
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus
- Antifungal resistance and susceptibility
- Clostridium difficile and Clostridium perfringens research
- HIV/AIDS drug development and treatment
- Clinical Biochemistry top 2%
- Bacterial Identification and Susceptibility Testing
Papers in
-
- HIV/AIDS drug development and treatment 5
- Antimicrobial Resistance in Staphylococcus 2
- Virology 3
- HIV Research and Treatment 3
- Co-authors
- Michel Delmée (3 shared papers)Jean‐Luc Gala (3 shared papers)Pascal Vannuffel (2 shared papers)G. Wauters (3 shared papers)Jacques Gigi (3 shared papers)H Ezzedine (1 shared paper)Eric Jean Goffin (4 shared papers)J. L. Michaux (1 shared paper)
- Journals
- Clinical Infectious Diseases (2 papers)Clinical Nephrology (1 paper)Antiviral Therapy (1 paper)Journal of Antimicrobial Chemotherapy (1 paper)Research in Microbiology (1 paper)
- Partner nations
- BelgiumNetherlandsFrance
In The Last Decade
Bernard Vandercam
20 papers receiving 760 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 578
- Clinical Biochemistry 181
- Epidemiology 311
- Virology 34
- Small Animals 42
Countries citing papers authored by Bernard Vandercam
This map shows the geographic impact of Bernard Vandercam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Vandercam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Vandercam more than expected).
Fields of papers citing papers by Bernard Vandercam
This network shows the impact of papers produced by Bernard Vandercam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Vandercam. The network helps show where Bernard Vandercam may publish in the future.
Co-authors
The 25 scholars most cited alongside Bernard Vandercam, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 261 | |
| 2 | 1998 | 199 | |
| 3 | 1987 | 68 | |
| 4 | Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study. | 1987 | 59 |
| 5 | 1996 | 53 | |
| 6 | 1999 | 51 | |
| 7 | 1999 | 42 | |
| 8 | 2005 | 39 | |
| 9 | Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy. | 2005 | 12 |
| 10 | 2009 | 8 | |
| 11 | 2000 | 7 | |
| 12 | 2012 | 6 | |
| 13 | 1989 | 6 | |
| 14 | 2006 | 6 | |
| 15 | Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients | 1996 | 5 |
| 16 | HIV infection and rape. | 1992 | 4 |
| 17 | 1998 | 2 | |
| 18 | Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis. | 1997 | 1 |
| 19 | 2021 | 1 | |
| 20 | 1985 | 1 |
About Bernard Vandercam
Bernard Vandercam is a scholar working on Infectious Diseases, Virology, Epidemiology, Molecular Medicine and Oncology, having authored 21 papers that have together received 831 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (5 papers), Mycobacterium research and diagnosis (3 papers), HIV Research and Treatment (3 papers), Cancer Treatment and Pharmacology (2 papers), Antibiotic Resistance in Bacteria (2 papers), Neutropenia and Cancer Infections (2 papers), Antimicrobial Resistance in Staphylococcus (2 papers) and HIV-related health complications and treatments (2 papers). The work is most often cited by research in Infectious Diseases (578 citations), Clinical Biochemistry (181 citations), Epidemiology (311 citations), Virology (34 citations) and Small Animals (42 citations). Bernard Vandercam has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Michel Delmée, Jean‐Luc Gala, Pascal Vannuffel, G. Wauters, Jacques Gigi, H Ezzedine, Eric Jean Goffin, J. L. Michaux, V. Avesani and Chantal Doyen. Their work appears in journals such as Clinical Infectious Diseases, Clinical Nephrology, Antiviral Therapy, Journal of Antimicrobial Chemotherapy and Research in Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.